Literature DB >> 19850049

Analysis of angiogenesis induced by local IGF-1 expression after myocardial infarction using microSPECT-CT imaging.

Lawrence W Dobrucki1, Yoshiaki Tsutsumi, Leszek Kalinowski, Jarrod Dean, Mary Gavin, Sabyasachi Sen, Marivi Mendizabal, Albert J Sinusas, Ryuichi Aikawa.   

Abstract

Insulin-like growth factor-1 (IGF-1) has been found to exert favorable effects on angiogenesis in prior animal studies. This study explored the long-term effect of IGF-1 on angiogenesis using microSPECT-CT in infarcted rat hearts after delivering human IGF-1 gene by adeno-associated virus (AAV). Myocardial infarction (MI) was induced in Sprague-Dawley rats by ligation of the proximal anterior coronary artery and a total of 10(11) AAV-CMV-lacZ (control) or IGF-1 vectors were injected around the peri-infarct area. IGF-1 expression by AAV stably transduced heart muscle for up to 16 weeks post-MI and immunohistochemistry revealed a remarkable increase in capillary density. A (99m)Tc-labeled RGD peptide (NC100692, GE Healthcare) was used to assess temporal and regional alpha(v) integrin activation. Rats were injected with NC100692 followed by (201)Tl chloride and in vivo microSPECT-CT imaging was performed. After imaging, hearts were excised and cut for quantitative gamma-well counting (GWC). NC100692 retention was significantly increased in hypoperfused regions of both lacZ and IGF-1 rats at 4 and 16 weeks post-MI. Significantly higher activation of alpha(v) integrin was observed in IGF-1 rats at 4 weeks after treatment compared with control group, although the activation was lower in the IGF-1 group at 16 weeks. Local IGF-1 gene delivery by AAV can render a sustained transduction and improve cardiac function post-MI. IGF-1 expression contributes to enhanced alpha(v) integrin activation which is linked to angiogenesis. MicroSPECT-CT imaging with (99m)Tc-NC100692 and quantitative GWC successfully assessed differences in alpha(v) integrin activation between IGF-1-treated and control animals post-MI. (c) 2009. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19850049      PMCID: PMC2866767          DOI: 10.1016/j.yjmcc.2009.10.008

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  35 in total

Review 1.  Akt takes center stage in angiogenesis signaling.

Authors:  S Dimmeler; A M Zeiher
Journal:  Circ Res       Date:  2000 Jan 7-21       Impact factor: 17.367

2.  Cardiomyocyte-specific gene expression following recombinant adeno-associated viral vector transduction.

Authors:  Ryuichi Aikawa; Gordon S Huggins; Richard O Snyder
Journal:  J Biol Chem       Date:  2002-03-11       Impact factor: 5.157

3.  Adeno-associated viral vector-mediated vascular endothelial growth factor gene transfer induces neovascular formation in ischemic heart.

Authors:  H Su; R Lu; Y W Kan
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

4.  Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia.

Authors:  A Kawamoto; H C Gwon; H Iwaguro; J I Yamaguchi; S Uchida; H Masuda; M Silver; H Ma; M Kearney; J M Isner; T Asahara
Journal:  Circulation       Date:  2001-02-06       Impact factor: 29.690

5.  Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene.

Authors:  Luis G Melo; Reitu Agrawal; Lunan Zhang; Mojgan Rezvani; Abeel A Mangi; Afshin Ehsan; Daniel P Griese; Giorgio Dell'Acqua; Michael J Mann; Junichi Oyama; Shaw-Fang Yet; Matthew D Layne; Mark A Perrella; Victor J Dzau
Journal:  Circulation       Date:  2002-02-05       Impact factor: 29.690

6.  Growth hormone increases regional coronary blood flow and capillary density in aged rats.

Authors:  A S Khan; C D Lynch; D C Sane; M C Willingham; W E Sonntag
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-08       Impact factor: 6.053

7.  Cardiac-specific IGF-1 expression attenuates dilated cardiomyopathy in tropomodulin-overexpressing transgenic mice.

Authors:  Sara Welch; David Plank; Sandra Witt; Betty Glascock; Erik Schaefer; Stefano Chimenti; Anna Maria Andreoli; Federica Limana; Annarosa Leri; Jan Kajstura; Piero Anversa; Mark A Sussman
Journal:  Circ Res       Date:  2002-04-05       Impact factor: 17.367

8.  Adverse effects of recombinant human insulin-like growth factor I in obese insulin-resistant type II diabetic patients.

Authors:  N Jabri; D S Schalch; S L Schwartz; J S Fischer; M S Kipnes; B J Radnik; N J Turman; V S Marcsisin; H P Guler
Journal:  Diabetes       Date:  1994-03       Impact factor: 9.461

9.  Myogenic Akt signaling regulates blood vessel recruitment during myofiber growth.

Authors:  Akihiro Takahashi; Yasuko Kureishi; Jiang Yang; Zhengyu Luo; Kun Guo; Debabrata Mukhopadhyay; Yuri Ivashchenko; Didier Branellec; Kenneth Walsh
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

Review 10.  Growth hormone, insulin-like growth factor-1 and the aging cardiovascular system.

Authors:  Amir S Khan; David C Sane; Thomas Wannenburg; William E Sonntag
Journal:  Cardiovasc Res       Date:  2002-04       Impact factor: 10.787

View more
  37 in total

1.  Angiotensin II receptor blocker reverses heart failure by attenuating local oxidative stress and preserving resident stem cells in rats with myocardial infarction.

Authors:  Zhuzhi Wen; Zun Mai; Yangxin Chen; Jingfeng Wang; Dengfeng Geng
Journal:  Am J Transl Res       Date:  2018-08-15       Impact factor: 4.060

2.  State-of-the-Art Methods for Evaluation of Angiogenesis and Tissue Vascularization: A Scientific Statement From the American Heart Association.

Authors:  Michael Simons; Kari Alitalo; Brian H Annex; Hellmut G Augustin; Craig Beam; Bradford C Berk; Tatiana Byzova; Peter Carmeliet; William Chilian; John P Cooke; George E Davis; Anne Eichmann; M Luisa Iruela-Arispe; Eli Keshet; Albert J Sinusas; Christiana Ruhrberg; Y Joseph Woo; Stefanie Dimmeler
Journal:  Circ Res       Date:  2015-04-30       Impact factor: 17.367

Review 3.  Angiogenic growth factors in myocardial infarction: a critical appraisal.

Authors:  Hemalatha Thiagarajan; UmaMaheswari Thiyagamoorthy; Iswariya Shanmugham; Gunadharini Dharmalingam Nandagopal; Anbukkarasi Kaliyaperumal
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

Review 4.  Future directions for therapeutic strategies in post-ischaemic vascularization: a position paper from European Society of Cardiology Working Group on Atherosclerosis and Vascular Biology.

Authors:  Andrea Caporali; Magnus Bäck; Mat J Daemen; Imo E Hoefer; Elizabeth A Jones; Esther Lutgens; Christian M Matter; Marie-Luce Bochaton-Piallat; Arndt F Siekmann; Judith C Sluimer; Sabine Steffens; José Tuñón; Cecile Vindis; Jolanda J Wentzel; Seppo Ylä-Herttuala; Paul C Evans
Journal:  Cardiovasc Res       Date:  2018-09-01       Impact factor: 10.787

5.  IGF1 3'UTR functions as a ceRNA in promoting angiogenesis by sponging miR-29 family in osteosarcoma.

Authors:  Shuming Gao; Cai Cheng; Hanwen Chen; Min Li; Kehun Liu; Guangya Wang
Journal:  J Mol Histol       Date:  2016-01-12       Impact factor: 2.611

6.  Molecular Imaging of Healing After Myocardial Infarction.

Authors:  Nivedita K Naresh; Tamar Ben-Mordechai; Jonathan Leor; Frederick H Epstein
Journal:  Curr Cardiovasc Imaging Rep       Date:  2011-02-01

7.  CRISPR-Cas9-induced IGF1 gene activation as a tool for enhancing muscle differentiation via multiple isoform expression.

Authors:  Matthew J Roberston; Suchi Raghunathan; Vladimir N Potaman; Fan Zhang; M David Stewart; Bradley K McConnell; Robert J Schwartz
Journal:  FASEB J       Date:  2019-11-25       Impact factor: 5.191

8.  Development and application of a multimodal contrast agent for SPECT/CT hybrid imaging.

Authors:  Jason M Criscione; Lawrence W Dobrucki; Zhen W Zhuang; Xenophon Papademetris; Michael Simons; Albert J Sinusas; Tarek M Fahmy
Journal:  Bioconjug Chem       Date:  2011-09-06       Impact factor: 4.774

Review 9.  Molecular imaging in cardiovascular disease: Which methods, which diseases?

Authors:  Jonathan R Lindner; Albert Sinusas
Journal:  J Nucl Cardiol       Date:  2013-12       Impact factor: 5.952

10.  Specific uptake of 99mTc-NC100692, an αvβ3-targeted imaging probe, in subcutaneous and orthotopic tumors.

Authors:  Jason L J Dearling; Jessica W Barnes; Dipak Panigrahy; Robert E Zimmerman; Frederic Fahey; S Ted Treves; Matthew S Morrison; Mark W Kieran; Alan B Packard
Journal:  Nucl Med Biol       Date:  2013-05-20       Impact factor: 2.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.